Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 9,873.8%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,873.8% |
CannBioRx Life Sciences (ATNFW) | 4,287.76% |
DeFi Development (DFDV) | 2,582.42% |
Blue Gold Limited Warrant (BGLWW) | 2,300% |
WW International, Inc Common Stock (WW) | 2,248.85% |
HCM II Acquisition (HONDW) | 2,184.48% |
Zepp Health (ZEPP) | 1,572.31% |
Oncology Institute (TOIIW) | 1,483.33% |
Triumph (TGI) | 1,458.74% |
CEA Industries (BNCWW) | 1,242.28% |
Newegg Commerce (NEGG) | 1,239% |
Oncology Institute (TOI) | 1,220.26% |
Diginex Limited Ordinary Shares (DGNX) | 1,208.22% |
K Wave Media (KWMWW) | 1,161.17% |
CEA Industries (VAPEW) | 1,108.05% |
USA Rare Earth (USARW) | 1,012% |
SRM Entertainment, Inc Common Stock (SRM) | 985.28% |
Webull Corporation Warrants (BULLW) | 981.36% |
Ainos (AIMDW) | 914.2% |
Cohen Circle Acquisition Corp I Warrant (CCIRW) | 894.2% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 882.32% |
Kindly (NAKA) | 869.35% |
Abivax SA American Depositary Shares (ABVX) | 866.99% |
Global Interactive Technologies (GITS) | 862.66% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 858.33% |
